138.09 USD
-4.1 (-2.88%)
138.09 USD
0 (0%)
Overall MASI gets a fundamental rating of 4 out of 10. We evaluated MASI against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of MASI get a neutral evaluation. Nothing too spectacular is happening here. MASI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
MASI had positive earnings in the past year.
MASI had a positive operating cash flow in the past year.
MASI had positive earnings in 4 of the past 5 years.
In the past 5 years MASI always reported a positive cash flow from operatings.
1.2 Ratios
MASI has a Return On Assets (-31.33%) which is in line with its industry peers.
MASI has a Return On Equity (-70.30%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 9.63%, MASI belongs to the top of the industry, outperforming 88.83% of the companies in the same industry.
MASI had an Average Return On Invested Capital over the past 3 years of 4.63%. This is below the industry average of 8.78%.
The last Return On Invested Capital (9.63%) for MASI is above the 3 year average (4.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROIC | 9.63% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
1.3 Margins
MASI has a better Operating Margin (10.29%) than 78.72% of its industry peers.
In the last couple of years the Operating Margin of MASI has declined.
MASI's Gross Margin of 54.96% is in line compared to the rest of the industry. MASI outperforms 52.13% of its industry peers.
In the last couple of years the Gross Margin of MASI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% |
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
2. Health
2.1 Basic Checks
MASI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, MASI has more shares outstanding
The number of shares outstanding for MASI remains at a similar level compared to 5 years ago.
Compared to 1 year ago, MASI has an improved debt to assets ratio.
2.2 Solvency
MASI has an Altman-Z score of 7.24. This indicates that MASI is financially healthy and has little risk of bankruptcy at the moment.
MASI has a better Altman-Z score (7.24) than 86.17% of its industry peers.
The Debt to FCF ratio of MASI is 2.96, which is a good value as it means it would take MASI, 2.96 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.96, MASI belongs to the top of the industry, outperforming 84.57% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that MASI is somewhat dependend on debt financing.
The Debt to Equity ratio of MASI (0.69) is worse than 67.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Altman-Z | 7.24 |
ROIC/WACC1.17
WACC8.22%
2.3 Liquidity
MASI has a Current Ratio of 2.84. This indicates that MASI is financially healthy and has no problem in meeting its short term obligations.
MASI has a Current ratio (2.84) which is in line with its industry peers.
A Quick Ratio of 1.92 indicates that MASI should not have too much problems paying its short term obligations.
MASI has a Quick ratio (1.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.77% over the past year.
MASI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.86% yearly.
The Revenue for MASI has decreased by -16.03% in the past year. This is quite bad
MASI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.43% yearly.
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
3.2 Future
MASI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.11% yearly.
MASI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.10% yearly.
EPS Next Y27.12%
EPS Next 2Y17.7%
EPS Next 3Y15.75%
EPS Next 5Y12.11%
Revenue Next Year-27.11%
Revenue Next 2Y-11.36%
Revenue Next 3Y-5.25%
Revenue Next 5Y-1.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.31, MASI is valued on the expensive side.
Based on the Price/Earnings ratio, MASI is valued a bit cheaper than the industry average as 78.72% of the companies are valued more expensively.
MASI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.37, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 23.29 indicates a rather expensive valuation of MASI.
MASI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MASI is cheaper than 74.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, MASI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.31 | ||
| Fwd PE | 23.29 |
4.2 Price Multiples
70.74% of the companies in the same industry are more expensive than MASI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MASI indicates a somewhat cheap valuation: MASI is cheaper than 75.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.3 | ||
| EV/EBITDA | 33.92 |
4.3 Compensation for Growth
MASI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MASI's earnings are expected to grow with 15.75% in the coming years.
PEG (NY)0.9
PEG (5Y)4.15
EPS Next 2Y17.7%
EPS Next 3Y15.75%
5. Dividend
5.1 Amount
No dividends for MASI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
138.09
-4.1 (-2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners107.26%
Inst Owner Change-2.72%
Ins Owners0.18%
Ins Owner Change1.07%
Market Cap7.42B
Revenue(TTM)1.72B
Net Income(TTM)-569.40M
Analysts82.67
Price Target188.1 (36.22%)
Short Float %7.55%
Short Ratio5.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.18%
Min EPS beat(2)6.64%
Max EPS beat(2)7.73%
EPS beat(4)4
Avg EPS beat(4)9.88%
Min EPS beat(4)6.64%
Max EPS beat(4)14.9%
EPS beat(8)8
Avg EPS beat(8)11.58%
EPS beat(12)12
Avg EPS beat(12)9.84%
EPS beat(16)16
Avg EPS beat(16)9.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.35%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-1.35%
Max Revenue beat(4)-0.59%
Revenue beat(8)0
Avg Revenue beat(8)-1.1%
Revenue beat(12)1
Avg Revenue beat(12)-1.81%
Revenue beat(16)4
Avg Revenue beat(16)-1.23%
PT rev (1m)-1.44%
PT rev (3m)-1.44%
EPS NQ rev (1m)2.15%
EPS NQ rev (3m)2.15%
EPS NY rev (1m)0.09%
EPS NY rev (3m)0.09%
Revenue NQ rev (1m)-0.98%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.31 | ||
| Fwd PE | 23.29 | ||
| P/S | 4.32 | ||
| P/FCF | 39.3 | ||
| P/OCF | 35.69 | ||
| P/B | 9.16 | ||
| P/tB | 11.37 | ||
| EV/EBITDA | 33.92 |
EPS(TTM)5.68
EY4.11%
EPS(NY)5.93
Fwd EY4.29%
FCF(TTM)3.51
FCFY2.54%
OCF(TTM)3.87
OCFY2.8%
SpS31.93
BVpS15.08
TBVpS12.15
PEG (NY)0.9
PEG (5Y)4.15
Graham Number43.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROCE | 12.18% | ||
| ROIC | 9.63% | ||
| ROICexc | 12.27% | ||
| ROICexgc | 14.25% | ||
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% | ||
| FCFM | 11% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
ROICexc(3y)5.01%
ROICexc(5y)12.81%
ROICexgc(3y)9.36%
ROICexgc(5y)17.94%
ROCE(3y)5.86%
ROCE(5y)10.38%
ROICexgc growth 3Y-54.41%
ROICexgc growth 5Y-39.37%
ROICexc growth 3Y-57.67%
ROICexc growth 5Y-43.42%
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
F-Score6
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Debt/EBITDA | 2.41 | ||
| Cap/Depr | 34.11% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | 5.14 | ||
| Cash Conversion | 89.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 7.24 |
F-Score6
WACC8.22%
ROIC/WACC1.17
Cap/Depr(3y)60.07%
Cap/Depr(5y)110.25%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
EPS Next Y27.12%
EPS Next 2Y17.7%
EPS Next 3Y15.75%
EPS Next 5Y12.11%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
Revenue Next Year-27.11%
Revenue Next 2Y-11.36%
Revenue Next 3Y-5.25%
Revenue Next 5Y-1.1%
EBIT growth 1Y9.5%
EBIT growth 3Y-45.85%
EBIT growth 5Y-27.67%
EBIT Next Year42.43%
EBIT Next 3Y17.05%
EBIT Next 5Y13.17%
FCF growth 1Y423.12%
FCF growth 3Y-14.18%
FCF growth 5Y-0.52%
OCF growth 1Y1898.08%
OCF growth 3Y-9.48%
OCF growth 5Y-2.39%
MASIMO CORP / MASI FAQ
What is the fundamental rating for MASI stock?
ChartMill assigns a fundamental rating of 4 / 10 to MASI.
What is the valuation status for MASI stock?
ChartMill assigns a valuation rating of 5 / 10 to MASIMO CORP (MASI). This can be considered as Fairly Valued.
Can you provide the profitability details for MASIMO CORP?
MASIMO CORP (MASI) has a profitability rating of 4 / 10.
What is the financial health of MASIMO CORP (MASI) stock?
The financial health rating of MASIMO CORP (MASI) is 6 / 10.
How sustainable is the dividend of MASIMO CORP (MASI) stock?
The dividend rating of MASIMO CORP (MASI) is 0 / 10 and the dividend payout ratio is 0%.